Story at-a-glance
- Glioblastoma is considered one of the most aggressive brain cancers, with survival often limited to about a year, largely because tumors adapt by rewiring how they use nutrients and energy
- Tumors divert vitamin B3 (niacinamide) away from normal energy production into a pathway that supports their survival, suggesting a metabolic weakness that could potentially be targeted
- This altered pathway may drain key cellular resources, meaning cancer cells appear to burn through materials they need to grow, which may create an opportunity to disrupt their fuel supply
- In a Science Advances study, high-dose vitamin B3 therapy was associated with improved short-term outcomes in patients, with over 80% showing no disease progression at six months in early findings, along with stronger immune activity against tumors
- Supporting your body’s energy production and immune response through diet, lifestyle, and structured nutrient intake may help influence the same metabolic systems cancer depends on
Glioblastoma stands as one of the most aggressive brain cancers, with median survival ranging from just 12 to 15 months after diagnosis.1 This disease is characterized by persistent headaches, seizures, memory loss, confusion, and progressive neurological decline.
Once it takes hold, it disrupts normal brain function and often resists standard treatments, leaving patients with limited options and a steep decline in quality of life.
What makes this even more alarming is how little progress has occurred in extending survival, despite decades of research and treatment advances. Most patients receive a combination of surgery, chemotherapy, and radiation, along with steroids to control brain swelling.
Yet the drugs used to manage symptoms don’t act in isolation; they interact with the biology of the tumor itself in ways researchers are only beginning to map. At the same time, a growing body of research challenges the long-standing view of cancer as purely a genetic disease. Scientists now show that cancer cells rewire how they use nutrients and energy to support uncontrolled growth.
A common B vitamin sits unexpectedly at the center of this story — not because it directly treats cancer, but because of what tumors do when they encounter it, and what happens when you use that against them. Understanding how tumors hijack this nutrient pathway opens a new perspective on cancer itself, one that shifts attention away from mutations alone and toward the metabolic machinery keeping tumors alive.
Steroids and Niacinamide Expose a Metabolic Weakness in Tumors
A study published in Science Advances investigated how dexamethasone, a steroid routinely given to brain tumor patients, reshapes metabolism inside glioblastoma cells.2 Instead of focusing only on tumor size or growth, the researchers zoomed in on how cells handle niacinamide, a form of vitamin B3 that normally fuels cellular energy production.
They used advanced tools like metabolomics, which is a way to measure chemical changes inside cells, to map what happens after steroid exposure. This suggests cancer is not just about genes; it’s about how your cells process fuel.
•Tumors reroute niacinamide away from energy production — To understand why this matters, think of NAD+, the molecule your cells rely on to produce energy, as your cells’ master battery charger — present in every cell in your body and essential for hundreds of metabolic reactions. When something diverts the raw material needed to make it, cellular energy production suffers across the board.
In laboratory models (multiple glioblastoma cell lines) and human tumor samples, scientists found a dramatic shift: niacinamide stopped feeding into NAD+ and instead got converted into a different compound called N1-methylnicotinamide.*
In simple terms, the tumor diverts a key fuel source away from energy production and into a side pathway. In human patients, the study reported about a sevenfold higher buildup of this compound in tumor tissue compared to surrounding healthy brain. That suggests the tumor may be actively rewiring how it uses nutrients to survive.
•This metabolic detour becomes even more pronounced in real patients — When researchers gave labeled niacinamide to patients before surgery, they tracked exactly where it went. Inside tumor tissue, about 40% of that niacinamide ended up as N1-methylnicotinamide, while a smaller portion supported NAD+ production. That imbalance shows the tumor strongly favors this altered pathway.
This reveals a key insight: cancer cells fundamentally change how they handle nutrients you consume.
•Steroid treatment amplifies the problem inside tumors — Dexamethasone, the steroid routinely given to reduce brain swelling and keep patients comfortable, appears to accelerate the very metabolic process that helps the tumor survive. It does this by increasing the activity of an enzyme called NNMT, which acts like a switch that pushes niacinamide down the pathway the tumor has hijacked rather than toward energy production.
The study showed that steroid exposure consistently raised both the enzyme levels and the buildup of the altered metabolite in tumor cells. This effect appeared across different tumor models, showing it’s not a rare event. That means a common treatment you might assume is harmless in terms of metabolism actually reshapes how cancer cells operate at a deep level.
•Tumors accumulate far more of this compound than normal brain tissue — In studies involving animal models, levels of N1-methylnicotinamide were about 10 times higher in tumors than in healthy brain tissue. Even more striking, steroid treatment boosted this compound by 85% in tumors but not in normal brain.*
That selectivity tells you something important: the tumor environment reacts very differently to the same signal. This difference opens the door to targeting cancer without affecting healthy tissue in the same way.
Metabolic Stress Reveals a Targetable Weakness in Tumors
The researchers tested what happens when methionine, an amino acid needed for this pathway, is restricted. Under these conditions, laboratory tumor cell models showed reduced ability to maintain key chemical reactions and demonstrated slower growth.* So, when you remove part of the fuel supply that supports this altered pathway, the tumor struggles — disrupting the fuel may disrupt the system.
•The process drains key cellular resources — Converting niacinamide into N1-methylnicotinamide consumes methyl groups; think of these as your body’s universal keys, needed to switch genes on and off, neutralize toxins, and keep cells replicating properly. When the tumor burns through them to run this pathway, it’s depleting a resource every cell in your body depends on.
The study showed a drop in a ratio that reflects the cell’s ability to carry out these reactions. When this ratio falls, the cell’s internal balance gets disrupted. This means the tumor is burning through resources in a way that weakens its own system under the right conditions.
•Scientists identified a new way to detect tumors using this pathway — Because tumors produce so much of this altered compound, researchers developed an imaging approach using labeled niacinamide to visualize tumors in real time. This gives clinicians a clearer way to see where tumors are active based on metabolism, not just structure. That shifts diagnosis from “what it looks like” to “how it behaves,” which gives a more precise picture.
•This research reframes cancer as a metabolic problem you can influence — By showing that glioblastoma cells actively divert a key nutrient away from energy production, the study highlights a core weakness in cancer metabolism. When you think about your own health, this reinforces a powerful concept: how your body processes nutrients influences disease at a cellular level.
Understanding that gives you a clearer path to take control, step by step, by focusing on the systems that drive cellular energy rather than just the symptoms you see on the surface.
•Excess niacinamide acts like a metabolic “drain” that weakens tumor fuel systems — In a related commentary, bioenergetic researcher Georgi Dinkov explains that when niacinamide levels rise, they saturate the enzyme responsible for making NAD+ and get redirected into another pathway that consumes methyl groups from methionine.3
Think of it this way: the tumor is running a metabolic process that backfires on itself. To handle all that niacinamide, it has to spend methyl groups — the same chemical currency it needs for dozens of other essential functions. Flood the system with niacinamide and you’re essentially forcing the tumor to spend faster than it can earn, draining its own reserves.
That’s the methyl sink. Framed this way, the same process observed in the study becomes a target; increasing niacinamide intake may help pressure the tumor’s fuel system by draining some of the inputs it needs to grow.
•This mechanism mimics methionine restriction, which has been associated with reduced tumor metabolism in research — Dinkov’s commentary highlights that excess niacinamide effectively forces the body into a state similar to methionine restriction, a strategy that has shown promise in slowing cancer growth in research and improving metabolic health. By consuming methionine through this pathway, tumor cells lose access to a key amino acid that acts as a metabolic regulator.
This reinforces what the study demonstrated when methionine restriction reduced tumor growth, but translates it into a practical insight: shifting how your body uses nutrients can recreate the same metabolic pressure on cancer cells without relying only on dietary restriction.
You may wonder whether this means you should also restrict methionine in your diet — a question the research raises but doesn’t fully resolve. Low-methionine diets have been studied in cancer contexts and show promise, but the more practical takeaway here is that niacinamide may create similar metabolic pressure without requiring strict dietary restriction.
Source link
